Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by ronrydellon Sep 09, 2013 4:46pm
280 Views
Post# 21727921

Today We Got Some clarity and some Direction Going Forward

Today We Got Some clarity and some Direction Going ForwardI was satisfied with the confirming information from September 3 and feel that there is little downside now from our $.70 share price. indeed, as DM indicated he's going to need some breathing room know as they plan their strategy going forward but I think there is enough information out there that we will eventually have a somewhat happy ending with a good solid licensing agreement t, probably with AZ.

Most of us should at least be made whole in the next 3 to 12 months at $3 to $4.00 so we just sit back and tolerate the wait and move on to new horizons.

The Dream. However, of the "big score" of years past is gone, IMHO, forever and it's still to bad we got an irrevocable "taint" back in late June. That shouldn't of had to happen, but it did. To the Cleveland Clinc I say...x$#^*+€£!
Bullboard Posts